In this case, the calculation is based on 60 companies, 20%. That would be $60 million, if we look at the amount of research invested by these 60 biotech companies in Canada.
On October 25th, 2006. See this statement in context.
On October 25th, 2006. See this statement in context.
October 25th, 2006 / 10:25 a.m.
President and Chief Executive Officer, Aeterna Zentaris Inc., Canada's Research-Based Pharmaceutical Companies (Rx&D)
In this case, the calculation is based on 60 companies, 20%. That would be $60 million, if we look at the amount of research invested by these 60 biotech companies in Canada.
See context to find out what was said next.